Outcome of Rituximab-Based Treatment for Post-Transplant Lymphoproliferative Disorder After Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Center Experience
Chengying Zhu(Chinese People's Liberation Army), Chunji Gao(Chinese PLA General Hospital), Liping Dou(Zhejiang Chinese Medical University), Lili Wang(University of Science and Technology of China), Yuchen Liu(Zhejiang Chinese Medical University), Xiaokai Wang(Tianjin Hospital), Yi Ding(Nanfang Hospital), Feiyan Wang(Chinese General Hospital College of Nursing and Liberal Arts), Shu Fang(Peking University), Li Wang(University of Science and Technology of China), Zhanxiang Liu(Tianjin University), Lixun Guan(Chinese General Hospital College of Nursing and Liberal Arts), Shasha Zhao(Chinese General Hospital College of Nursing and Liberal Arts)
Cited by 14
Related Papers
Development and validation of a radiopathomics model to predict pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a multicentre observational study
|The Lancet Digital Health|2021|334
Genomic and Transcriptomic Characterization of Natural Killer T Cell Lymphoma
|Cancer Cell|2020|238
Adaptive genic evolution in the <i>Drosophila</i> genomes
|Proceedings of the National Academy of Sciences|2007|227
Synthesizing AND gate genetic circuits based on CRISPR-Cas9 for identification of bladder cancer cells
|Nature Communications|2014|225